Modeling of αβ for late rectal toxicity from a randomized phase II study: Conventional versus hypofractionated scheme for localized prostate cancer

Journal of Experimental and Clinical Cancer Research

Volumn 28, Issue 1, 2009, Pages

  Marzi, Simona ^a   Saracino, Biancamaria ^a   Petrongari, Maria G ^a   Arcangeli, Stefano ^a   Gomellini, Sara ^a   Arcangeli, Giorgio ^a   Benassi, Marcello ^a   Landoni, Valeria ^a  

^a REGINA ELENA NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER PATIENT; CANCER RADIOTHERAPY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEASIBILITY STUDY; FOLLOW UP; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROSTATE CANCER; RADIATION DOSE; RADIATION INJURY; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; RECTUM DISEASE; AGED; COMPUTER ASSISTED RADIOTHERAPY; MALE; PATHOLOGY; PHASE 2 CLINICAL TRIAL; PROSTATE TUMOR; RADIATION EXPOSURE; RECTUM;

AGED; HUMANS; MALE; PROSTATIC NEOPLASMS; RADIOTHERAPY DOSAGE; RADIOTHERAPY, CONFORMAL; RECTUM;

EID: 69449102350     PISSN: None     EISSN: 17569966     Source Type: Journal    
DOI: 10.1186/1756-9966-28-117     Document Type: Article

References (34)

1. Fractionation and protraction for radiotherapy of prostate carcinoma. DJ Brenner EJ Hall, Int Int J Radiat Biol Oncol Phys 1999 43 1095 1101 10.1016/S0360-3016(98)00438-6 (Pubitemid 29144800)
2. Is / for prostate tumors really low? JF Fowler RJ Chappell MA Ritter, Int J Radiat Biol Oncol Phys 2001 50 1021 1031 10.1016/S0360-3016(01)01607-8 (Pubitemid 32594841)
3. Direct evidence that prostate tumors show high sensitivity to fractionation (low / ratio) comparable to late-responding normal tissue. DJ Brenner AA Martinez GK Edmundson C Mitchell HD Thames EP Armour, Int J Radiat Biol Oncol Phys 2002 52 6 13 10.1016/S0360-3016(01)02664-5 (Pubitemid 34041562)
4. The prospects for new treatments for prostate cancer. JF Fowler R Chappell MA Ritter, Int J Radiat Biol Oncol Phys 2002 52 3 5 10.1016/S0360-3016(01)02665-7 (Pubitemid 34041561)
5. Hypofractionation for prostate cancer radiotherapy. What are the issues? JD Brenner, Int J Radiat Oncol Biol Phys 2003 57 912 914 14575821
6. What is the / ratio for prostate cancer? Rationale for hypofractionated high-dose-rate brachytherapy. GM Duchesne LJ Peters, Int J Radiat Biol Oncol Phys 1999 44 747 748
7. Biologically Effective Doses in medium dose rate brachytherapy of cancer of the cervix. F Leborgne JF Fowler JH Leborgne E Zubizarreta R Chappell, Radiation Oncology Investigations 1997 5 289 299 10.1002/(SICI)1520-6823(1997)5: 6<289::AID-ROI5>3.0.CO;2-U 9436246
8. Fractionation and late rectal toxicity. DJ Brenner, Int J Radiat Biol Oncol Phys 2004 60 1013 1015 10.1016/j.ijrobp.2004.04.014 (Pubitemid 39440782)
9. Complication probability as assessed from dose volume histograms. JT Lyman, Radiat Res 1985 104 S13 S19 10.2307/3576626
10. Fitting of normal tissue tolerance data to an analytic function. C Burman GJ Kutcher B Emami M Goitein, Int J Radiat Biol Oncol Phys 1991 21 123 135
11. Histogram reduction method for calculating complication probabilities for three-dimensional treatment planning evaluations. GJ Kutcher C Burman L Brewster M Goitein R Mohan, Int J Radiat Biol Oncol Phys 1991 21 137 146
12. ICRU Report 62 Prescribing, recording, and reporting photon beam therapy. International Commission on Radiation Units and Measurements, (Supplement to ICRU Report 50) Bethesda, MD ICRU 1999
13. Toxicity Criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). JD Cox J Stetz TF Pajak, Int J Radiat Oncol Biol Phys 1995 31 1341 1346 10.1016/S0167-8140(84)80054-7 7713792
14. A new isoeffectcurve for change in dose per fraction. R Whithers HD Thames LJ Peters, Radiother Oncol 1984 2 173 174 10.1016/S1053-4296(05)80045-1
15. Brief summary of radiobiological principles in fractionated radiotherapy. JF Fowler, Semin Radiat Oncol 1992 2 16 21
16. Tolerance of normal tissue to therapeutic irradiation. B Emami J Lyman A Brown L Coia M Goitein JE Munzenfrider B Shank LJ Solin M Wesson, Int J Radiat Biol Oncol Phys 1991 21 109 122
17. The Application of Biological Models to Clinical Data. P Stavrev A Niemierko N Stavreva M Goitein, Physica Medica 2001 27 71 82 10.1016/j.radonc.2004.08.013
18. Fitting late rectal bleeding data using different NTCP models from an Italian multi-centric study (AIROPROS0101). T Rancati C Fiorino G Gagliardi GM Cattaneo G Sanguineti V Casanova Borca C Cozzarini G Fellin F Foppiano G Girelli L Menegotti A Piazzolla V Vavassori R Valdagni, Radiother Oncol 2004 73 21 32 10.1016/j.ijrobp.2006.03.034 15465142
19. Rectal bleeding, fecal incontinence, and high stool frequency after conformal radiotherapy for prostate cancer normal tissue complication probability modelling. STH Peeters MS Hoogeman WD Heemsbergen AAM Hart PCM Koper JV Lebesque, Int J Radiat Biol Oncol Phys 2006 66 11 19 10.1016/j.ijrobp.2006. 12.003
20. Relationships between rectal wall dose-volume constraints and radiobiologic indices of toxicity for patients with prostate cancer. S Marzi G Arcangeli B Saracino MG Petrongari V Bruzzaniti G Iaccarino V Landoni A Soriani M Benassi, Int J Radiat Biol Oncol Phys 2007 68 41 49 10.1016/j.ijrobp.2003.12. 033
21. Dose-volume response analysis of late rectal bleeding after radiotherapy for prostate cancer. SL Tucker R Cheung L Dong HH Liu HD Thames EH Huang D Kuban R Mohan, Int J Radiat Biol Oncol Phys 2004 59 353 365 10.1016/S0360-3016(00) 01414-0
22. Late rectal bleeding after conformal radiotherapy of prostate cancer II Volume effects and dose-volume histograms. A Jackson MW Skwarchuk MJ Zelefsky DM Cowen ES Venkatraman S Levegrun CM Burman GJ Kutcher Z Fuks SA Liebel CC Ling, Int J Radiat Biol Oncol Phys 2001 49 685 698 10.1016/j.ijrobp.2004.07.712
23. Comparison of rectal dose-wall histogram versus dose-volume histogram for modeling the incidence of late rectal bleeding after radiotherapy. SL Tucker L Dong R Cheung J Johnson R Mohan EH Huang HH Liu HD Thames D Kuban, Int J Radiat Biol Oncol Phys 2004 60 1589 1601 10.1200/JCO.2005.06.153
24. Randomized Trial Comparing Two Fractionation Schedules for Patients With Localized Prostate Cancer. H Lukka C Hayter JA Julian P Warde WJ Morris M Gospodarowicz M Levine J Sathya R Choo H Prichard M Brundage W Kwan, J Clin Oncol 2005 23 6132 6138 10.1016/j.ijrobp.2004.07.695 16135479
25. Rectal bleeding after hypofractionated radiotherapy for prostate cancer: Correlation between clinical and dosimetric parameters and the incidence of grade 2 or worse rectal bleeding. T Akimoto H Muramatsu M Takahashi J Saito Y Kitamoto K Harashima Y Miyazawa M Yamada K Ito K Kurokawa H Yamanaka T Nakano N Mitsuhashi H Niibe, Int J Radiat Biol Oncol Phys 2004 60 1033 1039 10.1016/S0360-3016(03)00752-1
26. Hypofractionated conformal radiotherapy in carcinoma of the prostate five-year outcome analysis. JE Livsey RA Cowan JP Wylie R Swindell G Read VS Khoo JP Logue, Int J Radiat Biol Oncol Phys 2003 57 1254 1259
27. Hypofractionated intensity modulated irradiation for localized prostate cancer, results from a phase I/II feasibility study. S Junius K Haustermans B Bussels R Oyen B Vanstraelen T Depuydt J Verstraete S Joniau H Van Poppel, Radiation Oncology 2007 229 1 10 10.1016/j.ijrobp.2007.01.067 (Pubitemid 47176809)
28. Hypofractionated intensity-modulated radiotherapy (70 Gy at 2.5 Gy per fraction) for localized prostate cancer Cliveland clinic experience. PA Kupelian TR Willoughby CA Reddy EA Klein A Mahadevan, Int J Radiat Biol Oncol Phys 2007 68 1424 1430 10.1016/j.ijrobp.2008.02.030
29. Reporting late rectal toxicity in prostate cancer patients treated with curative radiation treatment. SL Faria L Souhami B Joshua T Vuong CR Freeman, Int J Radiat Biol Oncol Phys 2008 72 777 781 10.1016/j.ijrobp.2004.12.052
30. Dose-volume analysis predictors for chronic rectal toxicity after treatment of prostate cancer with adaptive-guided radiotherapy. C Vargas A Martinez LL Kestin D Yan I Grills DS Brabbins DM Lockman J Liang GS Gustafson PY Chen FA Vicini JW Wong, Int J Radiat Biol Oncol Phys 2005 62 1297 1308 10.1016/j.ijrobp.2006.03.055 (Pubitemid 40982047)
31. Acute and late gastrointestinal toxicity after radiotherapy in prostate cancer patients: consequential late damage. WD Heemsbergen STH Peeters PC Koper MS Hoogeman JV Lebesque, Int J Radiat Biol Oncol Phys 2006 66 3 10 10.1016/S0167-8140(01)00429-7
32. Consequential late effects in normal tissues. W Dorr JH Hendry, Radioth Oncol 2001 61 223 231 10.1016/j.ijrobp.2005.01.015
33. Letter to the editor. C Fiorino G Sanguineti R Valdagni, Int J Radiat Biol Oncol Phys 2005 62 289 300 10.1016/j.ijrobp.2006.01.021
34. A study of the effect of setup errors and organ motion on prostate cancer treatment with IMRT. V Landoni B Saracino S Marzi M Gallucci MG Petrongari E Chianese M Benassi G Iaccarino A Soriani G Arcangeli, Int J Radiat Biol Oncol Phys 2006 65 587 594